Bridgewater-based Cosette Pharmaceuticals announced Feb. 20 it entered into an agreement to acquire Mayne Pharma Group Ltd. in a $430 million deal. Mayne is an Australian-headquartered specialty ...
Cosette Pharmaceuticals and Mayne Pharma have ended their $430M acquisition deal following a court ruling and disputes over alleged breaches.
Cosette Pharma announces US FDA approval and launch of first generic version of Cipro HC with 180 days Competitive Generic Therapy: Bridgewater, New Jersey Thursday, December 18, ...
Mayne Pharma Group ( ($AU:MYX) ) just unveiled an announcement. Mayne Pharma has terminated its Scheme Implementation Deed (SID) with Cosette due ...
Both parties' notices of termination follow a ruling from the Treasurer of Australia blocking the proposed transaction and the expiry of the end date under the Scheme Implementation Deed in November.
With a $430 million buyout of Australia’s Mayne Pharma locked down, Cosette Pharmaceuticals is looking to become a leading force in women’s healthcare. The New Jersey-based drugmaker agreed to ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire ...
Gift 5 articles to anyone you choose each month when you subscribe. American pharmaceutical giant Cosette has terminated its $672 million takeover bid for Adelaide-headquartered drug company Mayne ...
A bombshell report in The Age identified a customer who had put her handbag – a Saint Laurent Envelope Medium Chain Bag – through the official authentication process, only to be told it was not the ...
BRIDGEWATER, N.J., December 16, 2025--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated pharmaceutical company, announced today that the U.S. Food and Drug Administration ...